Skip to main content
Sanofi logo

Sanofi — Investor Relations & Filings

Ticker · SAN ISIN · FR0000120578 LEI · 549300E9PC51EN656011 PA Manufacturing
Open in API
Filings indexed 4,405 across all filing types
Latest filing 2026-02-16 Transaction in Own Shar…
Country FR France
Listing PA SAN

About Sanofi

https://www.sanofi.com/en/directory/

Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
Sanofi: Disclosure of trading in own shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Disclosure of trading in own shares' and explicitly states that Sanofi is declaring purchases of its own shares for a specific period (8 February 2020 to 12 February 2020). It includes a table detailing transaction volumes and weighted average prices. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2026-02-16 English
Communiqué de presse : L’étude sur Beyfortus publiée dans la revue The Lancet Infectious Diseases montre ses bénéfices chez les nourrissons au-delà de la première saison du VRS
Regulatory Filings Classification · 95% confidence The document is a press release from Sanofi announcing the publication of clinical study results for their product 'Beyfortus' in the medical journal 'The Lancet Infectious Diseases'. It details the study's findings, methodology, and implications for public health. It does not constitute a formal financial report, proxy statement, or regulatory filing required by an exchange, but rather a corporate communication regarding product research and development. As it does not fit into specific categories like 10-K, IR, or ER, and is a general corporate announcement, it is classified as a Regulatory Filing (RNS).
2026-02-16 French
Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Regulatory Filings Classification · 95% confidence The document is a press release from Sanofi announcing the publication of clinical study results for their product 'Beyfortus' in 'The Lancet Infectious Diseases'. It details the study's findings, methodology, and implications for public health. It does not constitute a formal financial report, proxy statement, or regulatory filing, but rather a corporate communication regarding product research and development. As it does not fit into specific categories like 10-K, IR, or CT, it falls under the general regulatory announcement category. FY 2026
2026-02-16 English
Communiqué de presse : Belén Garijo nommée Directrice générale de Sanofi
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new CEO (Belén Garijo) and the departure of the current CEO (Paul Hudson) at Sanofi. It details the transition process, the interim CEO appointment, and the background of the incoming executive. This falls squarely under the category of board and management changes.
2026-02-12 French
Press Release: Belén Garijo to become Chief Executive Officer of Sanofi
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new Chief Executive Officer (Belén Garijo) and the departure of the current CEO (Paul Hudson). It details the transition process, the appointment of an interim CEO, and the board's decision-making process regarding leadership. This falls squarely under the category of announcements regarding changes in senior management.
2026-02-12 English
6-K Filing
Foreign Filer Report
2026-02-12 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.